VEDOLIZUMAB COMPARED WITH INFLIXIMAB FOR PERIANAL FISTULA CLOSURE IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE

被引：0
|
作者：
Gold, Stephanie
Cohen-Mekelburg, Shirley A.
Schneider, Yecheskel
Bosworth, Brian P.
Scherl, Ellen
Steinlauf, Adam F.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1725
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [31] Consistency of treatment benefit with infliximab in patients with moderate-to-severe active Crohn's disease
    Vasiliauskas, E
    Targan, S
    Sands, B
    Hanauer, S
    Mayer, L
    Present, D
    Braakman, T
    DeWoody, K
    Schaible, T
    Rutgeerts, P
    GASTROENTEROLOGY, 1999, 116 (04) : A837 - A837
  • [32] Mapping Culturable Microbes of Perianal Fistula in Patients With Crohn's Disease
    Rozenberg, Felix D.
    Pan, Samuel
    Lacoste, Joshua
    Giselbrecht, Elisabeth
    Wong, Serre-yu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S958 - S959
  • [33] Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients
    Strik, Anne S.
    Lowenberg, Mark
    Buskens, Christianne J.
    Gecse, Krisztina B.
    Ponsioen, Cyriel, I
    Bemelman, Willem A.
    D'Haens, Geert R.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (04) : 453 - 458
  • [34] Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients
    Strik, A.
    Lowenberg, M.
    Ponsioen, C.
    Gecse, K.
    Buskens, C.
    Bemelman, W.
    D'Haens, G.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S4 - S4
  • [35] COMPARING CLOSURE RATE OF STEM CELL TRANSPLANTATION AND BIOLOGICS FOR PERIANAL FISTULA IN PATIENTS WITH CROHN'S DISEASE.
    Park, M.
    Yoon, Y.
    Lee, J.
    Yu, C.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [36] Factors Affecting Surgical Treatment With Infliximab Therapy in Perianal Fistula With Crohn Disease
    Lee, Jong Lyul
    ANNALS OF COLOPROCTOLOGY, 2019, 35 (05) : 225 - 226
  • [37] Effectiveness, safety and durability of vedolizumab in active moderate-severe Crohn's Disease
    Morales Bermudez, A. I.
    Bracho Gonzalez, M.
    Gomez Rodriguez, P.
    Olmedo Martin, R.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I489 - I490
  • [38] Outcome of moderate to severe pediatric Crohn's disease: Effect of infliximab therapy
    Rosh, Joel R.
    Hyams, Jeffrey
    Lerer, Trudy
    Markowitz, James
    Pfefferkorn, Marian
    Mack, David
    Otley, Anthony
    Kugathasan, Subra
    Evans, Joriathat
    Bousvaros, Athos
    Moyer, Susan
    Rothbaum, Robert
    Wyllie, Robert
    Tolia, Vasu
    Oliva-Hemker, Maria
    Mezoff, Adam
    Leleiko, Neal
    Delrosario, Fernando
    Crandall, Wallace
    Keljo, David
    Baldassano, Robert
    Griffiths, Anne
    GASTROENTEROLOGY, 2006, 130 (04) : A192 - A192
  • [39] Effectiveness, safety and durability of vedolizumab in active moderate-severe Crohn's Disease
    Morales Bermudez, A. I.
    Bracho Gonzalez, M.
    Gomez Rodriguez, P.
    Olmedo Martin, R.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I489 - I490
  • [40] Complex perianal fistula in a patient with Crohn's disease treated with fistula laser closure therapy - A video vignette
    Vela, Alberto Gallego
    Bujedo, Lourdes Gomez
    Membrives, Pablo Parra
    COLORECTAL DISEASE, 2023, 25 (11) : 2273 - 2275
12345